Literature DB >> 14625697

Inactivation of human glutamate dehydrogenase by aluminum.

S-J Yang1, J-W Huh, J E Lee, S Y Choi, T U Kim, S-W Cho.   

Abstract

Aluminum inactivated glutamate dehydrogenase (GDH) by a pseudo-first-order reaction at micromolar concentrations. A double-reciprocal plot gave a straight line with a k(inact) of 2.7 min(-1) and indicated the presence of a binding step prior to inactivation. The inactivation was strictly pH dependent and a marked increase in sensitivity to aluminum was observed as the pH decreased. At a pH higher than 8.5, no inactivation was observed. The completely inactivated GDH contained 2 mol of aluminum per mole of enzyme subunit monomer. When preincubated with enzyme, several chelators such as citrate, NaF, N-(2-hydroxyethyl) ethylenediaminetriacetic acid or ethylenediaminetriacetic acid efficiently protected the enzyme against the aluminum inactivation. In a related experiment, only citrate and NaF released the aluminum from the completely inactivated aluminum-enzyme complex and fully recovered the enzyme activity. Ferritin, NADP+, or nerve growth factor did not show any effects on the recovery of the aluminum-inactivated GDH activity. The dissociation constant for the aluminum-enzyme complex was calculated to be 5.3 microM. Although aluminum has been known to form a complex with nucleotides, no such effects were observed in the inactivation of GDH by aluminum as determined using GDHs mutated at the ADP-binding site, NAD+-binding site or GTP-binding site. Circular dichroism studies showed that the binding of aluminum to the enzyme induced a decrease in alpha helices and beta sheets and an increase in random coil. Therefore, inactivation of GDH by aluminum is suggested to be due to the conformational change induced by aluminum binding. These results suggest a possibility that aluminum-induced alterations in enzymes of the glutamate system may be one of the causes of aluminum-induced neurotoxicity.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14625697     DOI: 10.1007/s00018-003-3298-y

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  24 in total

1.  Task Force on Sudden Cardiac Death of the European Society of Cardiology.

Authors:  S G Priori; E Aliot; C Blomstrom-Lundqvist; L Bossaert; G Breithardt; P Brugada; A J Camm; R Cappato; S M Cobbe; C Di Mario; B J Maron; W J McKenna; A K Pedersen; U Ravens; P J Schwartz; M Trusz-Gluza; P Vardas; H J Wellens; D P Zipes
Journal:  Eur Heart J       Date:  2001-08       Impact factor: 29.983

2.  Clusters of ventricular tachycardias signify impaired survival in patients with idiopathic dilated cardiomyopathy and implantable cardioverter defibrillators.

Authors:  D Bänsch; D Böcker; J Brunn; M Weber; G Breithardt; M Block
Journal:  J Am Coll Cardiol       Date:  2000-08       Impact factor: 24.094

Review 3.  Risk stratification for sudden death in patients with coronary artery disease.

Authors:  Alfred E Buxton
Journal:  Heart Rhythm       Date:  2009-02-12       Impact factor: 6.343

4.  Effect of amiodarone and sotalol on ventricular defibrillation threshold: the optimal pharmacological therapy in cardioverter defibrillator patients (OPTIC) trial.

Authors:  Stefan H Hohnloser; Paul Dorian; Robin Roberts; Michael Gent; Carsten W Israel; Eric Fain; Jean Champagne; Stuart J Connolly
Journal:  Circulation       Date:  2006-07-03       Impact factor: 29.690

5.  Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction.

Authors:  Arthur J Moss; Wojciech Zareba; W Jackson Hall; Helmut Klein; David J Wilber; David S Cannom; James P Daubert; Steven L Higgins; Mary W Brown; Mark L Andrews
Journal:  N Engl J Med       Date:  2002-03-19       Impact factor: 91.245

6.  Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure.

Authors:  Gust H Bardy; Kerry L Lee; Daniel B Mark; Jeanne E Poole; Douglas L Packer; Robin Boineau; Michael Domanski; Charles Troutman; Jill Anderson; George Johnson; Steven E McNulty; Nancy Clapp-Channing; Linda D Davidson-Ray; Elizabeth S Fraulo; Daniel P Fishbein; Richard M Luceri; John H Ip
Journal:  N Engl J Med       Date:  2005-01-20       Impact factor: 91.245

7.  Long-term clinical course of patients after termination of ventricular tachyarrhythmia by an implanted defibrillator.

Authors:  Arthur J Moss; Henry Greenberg; Robert B Case; Wojciech Zareba; W Jackson Hall; Mary W Brown; James P Daubert; Scott McNitt; Mark L Andrews; Adam D Elkin
Journal:  Circulation       Date:  2004-12-06       Impact factor: 29.690

8.  Comparison of beta-blockers, amiodarone plus beta-blockers, or sotalol for prevention of shocks from implantable cardioverter defibrillators: the OPTIC Study: a randomized trial.

Authors:  Stuart J Connolly; Paul Dorian; Robin S Roberts; Michael Gent; Steven Bailin; Eric S Fain; Kevin Thorpe; Jean Champagne; Mario Talajic; Benoit Coutu; Gerian C Gronefeld; Stefan H Hohnloser
Journal:  JAMA       Date:  2006-01-11       Impact factor: 56.272

9.  Prevalence and predictors of electrical storm in patients with implantable cardioverter-defibrillator.

Authors:  Arash Arya; Majid Haghjoo; Mohammad Reza Dehghani; Amir Farjam Fazelifar; Mohammad-Hosein Nikoo; Ataollah Bagherzadeh; Mohammad Ali Sadr-Ameli
Journal:  Am J Cardiol       Date:  2006-02-01       Impact factor: 2.778

10.  Catheter ablation of recurrent scar-related ventricular tachycardia using electroanatomical mapping and irrigated ablation technology: results of the prospective multicenter Euro-VT-study.

Authors:  Hildegard Tanner; Gerhard Hindricks; Marius Volkmer; Steve Furniss; Volker Kühlkamp; Dominique Lacroix; Christian DE Chillou; Jesús Almendral; Domenico Caponi; Karl-Heinz Kuck; Hans Kottkamp
Journal:  J Cardiovasc Electrophysiol       Date:  2009-07-28
View more
  5 in total

Review 1.  Leucine metabolism in regulation of insulin secretion from pancreatic beta cells.

Authors:  Jichun Yang; Yujing Chi; Brant R Burkhardt; Youfei Guan; Bryan A Wolf
Journal:  Nutr Rev       Date:  2010-05       Impact factor: 7.110

2.  The influence of Omega3 fatty acids supplementation against aluminum-induced toxicity in male albino rats.

Authors:  Samah S Oda
Journal:  Environ Sci Pollut Res Int       Date:  2016-04-08       Impact factor: 4.223

3.  Exogenous phosphatidylcholine supplementation retrieve aluminum-induced toxicity in male albino rats.

Authors:  Asmaa Fahmy Khafaga
Journal:  Environ Sci Pollut Res Int       Date:  2017-05-18       Impact factor: 4.223

4.  Link between Aluminum and the Pathogenesis of Alzheimer's Disease: The Integration of the Aluminum and Amyloid Cascade Hypotheses.

Authors:  Masahiro Kawahara; Midori Kato-Negishi
Journal:  Int J Alzheimers Dis       Date:  2011-03-08

Review 5.  Aluminium toxicosis: a review of toxic actions and effects.

Authors:  Ikechukwu Onyebuchi Igbokwe; Ephraim Igwenagu; Nanacha Afifi Igbokwe
Journal:  Interdiscip Toxicol       Date:  2020-02-20
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.